Drugs / Lipoplus
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01814956 | Mar 2013 → May 2015 | — | B. Braun Melsungen AG | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03149653 | Jan 2012 → Jan 2016 | — | General University Hospital, Prague | Completed | No outcome recorded |
| Phase 4 | NCT00530738 | Sep 2007 → Jan 2014 | nutritional deficiency disease | B. Braun Melsungen AG | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lipoplus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01814956 ↗ |
| Modality | Other / unclassified | “i.v. fat emulsion for parenteral nutrition” NCT00530738 ↗ |
| Route | Intravenous | “i.v. fat emulsion for parenteral nutrition” NCT00530738 ↗ |